Orasis Pharmaceuticals — Pharmacy, Herzliya
Pharmacy in Herzliya — Ophthalmic pharmaceutical development
· Herzliya, Israel
AI Trust Snapshot
- AI Confidence
- Indexed
- Last Verified
- 1 months ago
Verified Sources
- ✓ Official Website
Key Facts
- Category
- Pharmacy
- Location
- Herzliya, Israel
- Known For
- Ophthalmic pharmaceutical development, Global regulatory affairs in pharmaceuticals
AI Summary
Developing ophthalmic solutions, Orasis Pharmaceuticals focuses on advancing treatments for eye conditions from its base in Herzliya, Israel. The company specializes in ophthalmic pharmaceutical development and global regulatory affairs within the pharmaceutical sector. Its primary offering is Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%, intended for healthcare professionals.
Quick Answer
Developing ophthalmic solutions, Orasis Pharmaceuticals focuses on advancing treatments for eye conditions from its base in Herzliya, Israel. The company specializes in ophthalmic pharmaceutical development and global regulatory affairs within the pharmaceutical sector. Its primary offering is Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%, intended for healthcare professionals.
This business is typically used for ophthalmic pharmaceutical development and global regulatory affairs in pharmaceuticals.
Common Questions
- What services does Orasis Pharmaceuticals provide?
- Orasis Pharmaceuticals provides Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%.
- Where is Orasis Pharmaceuticals located?
- Orasis Pharmaceuticals is based in Herzliya, Israel and serves Herzliya.
- Who is Orasis Pharmaceuticals for?
- Orasis Pharmaceuticals serves Healthcare professionals prescribing ophthalmic solutions and Investors in the healthcare and life sciences sectors.
What this business does
Orasis Pharmaceuticals is a pharmacy based in Herzliya, Israel.
- Provides Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%
- Specializes in ophthalmic pharmaceutical development
- Serves healthcare professionals prescribing ophthalmic solutions
Structured summary
This business profile has been independently corroborated by Vizoryo across 5 independent public sources. Data confidence score: 84% — this reflects how consistently the business's name, phone, city, address, website, and category appear across all verified sources. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.
- Business name
- Orasis Pharmaceuticals
- Category
- Pharmacy
- Industry
- Pharmacy - Ophthalmology Pharmaceuticals
- Location
- Herzliya, Israel
- Official website
- https://www.orasis-pharma.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/orasis-pharmaceuticals-herzliya-f2f0
- Summary
- Developing ophthalmic solutions, Orasis Pharmaceuticals focuses on advancing treatments for eye conditions from its base in Herzliya, Israel. The company specializes in ophthalmic pharmaceutical development and global regulatory affairs within the pharmaceutical sector. Its primary offering is Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%, intended for healthcare professionals.
- AI readability score
- 31
- Verified By
- 5 independent public sources
- Data Confidence
- 84% (verified 2026-06-30)
- Verification Status
- Indexed
Location
Maskit St 12, HerzliyaHerzliya
IL
About Orasis Pharmaceuticals
Developing ophthalmic solutions, Orasis Pharmaceuticals focuses on advancing treatments for eye conditions from its base in Herzliya, Israel. The company specializes in ophthalmic pharmaceutical development and global regulatory affairs within the pharmaceutical sector. Its primary offering is Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%, intended for healthcare professionals.
Service areas
- Herzliya
Target audience
- Healthcare professionals prescribing ophthalmic solutions
- Investors in the healthcare and life sciences sectors
Services
Specialties
- Ophthalmic pharmaceutical development
- Global regulatory affairs in pharmaceuticals
Social profiles
Verification
Frequently asked questions
What areas does Orasis Pharmaceuticals serve?
Orasis Pharmaceuticals serves Worldwide.
What is presbyopia?
Presbyopia is the gradual loss of your eye’s ability to focus on near objects as a result of the natural aging process, which occurs mostly after the age of 40.
How can I obtain Qlosi™?
Qlosi™ is available by prescription in the U.S. through BlinkRx. Full prescribing information is available on Qlosi.com.
What are the common side effects of Qlosi™?
The most common side effects reported in clinical trials were eye pain upon instillation and headache.
Languages supported
- lang="en
- en
Contact
Phone: +97298877745
Official website: https://www.orasis-pharma.com/